Note 17 - Acquisitions (Tables)

12 Months Ended

Dec. 31, 2022

Notes Tables

Schedule of Business Acquisitions, by Acquisition [Table Text Block]

Merger consideration shares		530,502
BioLife stock price (as of September 1, 2021)	$	60.50
Value of issued shares	$	32,095
plus: Fair value of BioLife’s existing investment in Sexton	$	7,951
less: Net working capital adjustment	$	(118	)
Merger Consideration	$	39,928

BioLife shares outstanding (as of March 19, 2021)		33,401,359
Merger consideration percentage		19.9	%
Merger consideration shares		6,646,870
less: Merger consideration shares withheld to satisfy outstanding GCI stockholder obligations to GCI		10,400
Subtotal		6,636,470
BioLife stock price (as of May 3, 2021)	$	35.07
Value of issued shares	$	232,741
plus: Settlement of BioLife prepaid deposits	$	2,152
plus: Net settlement of BioLife accounts receivable	$	16
Merger Consideration	$	234,909

Cash consideration	$	15,000
Stock consideration		17,916
Contingent consideration		3,663
Working capital adjustment		(53	)
Total consideration transferred	$	36,526

Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]

Cash	$	1,516
Accounts receivable, net		492
Inventory		1,310
Prepaid expenses and other current assets		670
Property, plant and equipment, net		737
Operating lease right-of-use assets, net		470
Developed technology		4,132
Customer relationships		2,276
Tradenames		2,324
Non-compete agreements		90
Goodwill		28,470
Accounts payable		(291	)
Lease liabilities, operating		(470	)
Deferred tax liability		(1,482	)
Other liabilities		(316	)
Fair value of net assets acquired	$	39,928

Cash	$	43
Accounts receivable, net		7,076
Inventory		15,547
Prepaid expenses and other current assets		639
Property, plant and equipment, net		3,512
Operating lease right-of-use assets, net		1,741
Financing lease right-of-use assets, net		114
Long-term deposits and other assets		4
Developed technology		18,140
Customer relationships		7,020
Tradenames		26,640
Non-compete agreements		1,240
In-process research and development		67,440
Goodwill		137,822
Accounts payable		(9,837	)
Line of credit		(4,231	)
Lease liabilities, operating		(1,880	)
Lease liabilities, financing		(114	)
Long-term debt		(4,410	)
Deferred tax liability		(24,133	)
Other liabilities		(7,464	)
Fair value of net assets acquired	$	234,909

Cash	$	500
Accounts receivable, net		945
Prepaid expenses and other current assets		31
Property, plant and equipment, net		3,400
Customer relationships		7,420
Tradenames		4,020
Non-compete agreements		660
Goodwill		24,943
Other assets		1,547
Accounts payable		(885	)
Deferred tax liability		(3,297	)
Other liabilities		(2,758	)
Fair value of net assets acquired	$	36,526

Schedule of Acquired Finite-Lived Intangible Assets by Major Class [Table Text Block]

	Fair Value		Useful Life (Years)
Developed technology	$	4,132	5	-	9
Customer relationships		2,276	2
Tradenames		2,324	11
Non-compete agreements		90	1
Total identifiable intangible assets	$	8,822

	Fair Value		Useful Life (Years)
Developed technology	$	18,140		6
Customer relationships		7,020		12
Tradenames		26,640		15
Non-compete agreements		1,240		4
In-process research and development		67,440		N/A
Total identifiable intangible assets	$	120,480

	Fair Value		Useful Life (Years)
Customer relationships	$	7,420		14
Tradenames		4,020		19
Non-compete agreements		660		4
Total identifiable intangible assets	$	12,100

Business Acquisition, Pro Forma Information [Table Text Block]

	2021			2020
(In thousands)	(unaudited)			(unaudited)
Total revenue	$	122,494		$	50,856
Net loss	$	(9,860	)	$	(1,028	)

	2021			2020
(In thousands)	(unaudited)			(unaudited)
Total revenue	$	143,732		$	87,370
Net income (loss)	$	(16,375	)	$	501

	2020
(In thousands)	(unaudited)
Total revenue	$	52,613
Net income	$	1,798